Avyxa Holdings Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AVYXA HOLDINGS
AVYXA HOLDINGS has twelve approved drugs.
There are five US patents protecting AVYXA HOLDINGS drugs.
Summary for Avyxa Holdings
| US Patents: | 5 |
| Tradenames: | 12 |
| Ingredients: | 12 |
| NDAs: | 12 |
Drugs and US Patents for Avyxa Holdings
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avyxa Holdings | AVGEMSI | gemcitabine hydrochloride | SOLUTION;INTRAVENOUS | 219920-001 | Jun 27, 2025 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Avyxa Holdings | AVGEMSI | gemcitabine hydrochloride | SOLUTION;INTRAVENOUS | 219920-002 | Jun 27, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Avyxa Holdings | FAVLYXA | fluorouracil | SOLUTION;INTRAVENOUS | 220201-001 | Feb 20, 2026 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Avyxa Holdings | DOCIVYX | docetaxel | SOLUTION;INTRAVENOUS | 215813-001 | Nov 22, 2022 | RX | Yes | Yes | 10,398,785 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Avyxa Holdings | AXTLE | pemetrexed dipotassium | POWDER;INTRAVENOUS | 210661-002 | Jun 28, 2024 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Avyxa Holdings Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Poland | 3270912 | ⤷ Start Trial |
| China | 111728940 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2016149162 | ⤷ Start Trial |
| China | 111714449 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2016005962 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Avyxa Holdings Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1667986 | 92172 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: SOLVAT ACETONIQUE DU CABAZITAXEL, OU DESIGNE SOLVAT ACETONIQUE DU DIMETHOXY DOCETAXEL OU SOLVAT ACETONIQUE DU (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4-ACETOXY-2A-BENZOYLOXY-5BETA,20-EPOXY-1-HYDROXY-7BETA,10A-DIMETHOXY-9-OXO-TAX-11-ENE-13A-YLE(ACETONATE DU CABAZITAXEL) |
| 0748320 | 08C0019 | France | ⤷ Start Trial | PRODUCT NAME: FOSAPREPITANT DIMEGLUMINE; REGISTRATION NO/DATE: EU/1/07/437/001 20080111 |
| 2785706 | C02785706/01 | Switzerland | ⤷ Start Trial | PRODUCT NAME: FOSNETUPITANT, PALONOSETRON.; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 68290 01.09.2022 |
| 1667986 | 28/2013 | Austria | ⤷ Start Trial | PRODUCT NAME: DIMETHOXYDOCETAXEL-ACETONSOLVAT (CABAZITAXEL-ACETONSOLVAT); REGISTRATION NO/DATE: EU/1/11/676/001 20110317 |
| 0122707 | SPC/GB95/031 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: GEMCITABINE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY- ACCEPTABLE SALT; REGISTERED: NL RVG17854 19950327; UK 00006/0301 19951026; UK 00006/0302 19951026 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
